Eric Venker's Net Worth
$37.5 Million
Who is Eric Venker?
Eric Venker has an estimated net worth of $37.5 Million. This is based on reported shares across multiple companies, which include Roivant Sciences Ltd., Arbutus Biopharma Corp, Immunovant, Inc., and Axovant Gene Therapies Ltd..
SEC CIK
Eric Venker's CIK is 0001801917
Past Insider Trading and Trends
2023 was Eric Venker's most active year for acquiring shares with 31 total transactions. Eric Venker's most active month to acquire stocks was the month of April. 2023 was Eric Venker's most active year for disposing of shares, totalling 75 transactions. Eric Venker's most active month to dispose stocks was the month of April. 2023 saw Eric Venker paying a total of $15,015,000.00 for 3,900,000 shares, this is the most they've acquired in one year. In 2023 Eric Venker cashed out on 8,088,363 shares for a total of $43,834,641.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Roivant Sciences Ltd. (ROIV) Snapshot price: $10.395
President & COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.34% | -10.95K |
$10.80 | -$118,206.00 | 457.25K |
Jun 20
| |||
Form 4
| -3.31% | -16.00K |
$11.37 | -$181,954.11 | 468.2K |
May 20
| |||
Form 4
| -3.20% | -16.00K |
$10.46 | -$167,380.92 | 484.2K |
Apr 20
| |||
Form 4
| -3.10% | -16.00K |
$10.01 | -$160,190.03 | 500.2K |
Mar 20
| |||
Form 4
| -3.01% | -16.00K |
$11.54 | -$184,663.08 | 516.21K |
Feb 20
| |||
Form 4
|
—
|
0
|
$7.39 | -$685,436.50 | 532.21K |
Feb 9
| |||
Form 4
| -2.27% | -12.38K |
$10.35 | -$128,101.95 | 532.21K |
Jan 20
| |||
Form 4
| -2.85% | -16.00K |
$9.96 | -$159,389.88 | 544.58K |
Dec 20
| |||
Form 4
| -2.87% | -16.55K |
$8.68 | -$143,645.32 | 560.59K |
Nov 22
| |||
Form 4
| -3.07% | -18.26K |
$8.99 | -$164,166.39 | 577.14K |
Oct 24
| |||
Form 4
|
—
|
0
|
$7.14 | -$7,900,989.82 | 595.4K |
Oct 2 - Oct 5
| |||
Form 4
|
—
|
0
|
$8.44 | -$4,585,000.00 | 595.4K |
Sep 27
| |||
Form 4
| -2.68% | -16.42K |
$10.19 | -$167,279.04 | 595.4K |
Sep 22
| |||
Form 4
|
—
|
0
|
$8.02 | -$887,626.20 | 611.81K |
Sep 8
| |||
Form 4
|
—
|
0
|
$7.88 | -$757,579.40 | 611.81K |
Sep 1 - Sep 6
| |||
Form 4
| -2.56% | -16.11K |
$10.83 | -$174,417.15 | 611.81K |
Aug 22
| |||
Form 4
|
—
|
0
|
$7.87 | -$480,880.44 | 627.92K |
Aug 14
| |||
Form 4
|
—
|
0
|
$7.89 | -$360,602.32 | 627.92K |
Aug 3
| |||
Form 4
|
—
|
0
|
$7.88 | -$1,572,832.08 | 627.92K |
Jul 31 - Aug 2
| |||
Form 4
|
—
|
0
|
$7.38 | -$886,506.38 | 627.92K |
Jul 25 - Jul 27
| |||
Form 4
| -2.53% | -16.30K |
$7.52 | -$2,927,289.97 | 627.92K |
Jul 20 - Jul 24
| |||
Form 4
| -2.41% | -15.88K |
$10.01 | -$158,978.82 | 644.22K |
Jun 22
| |||
Form 4
|
—
|
0
|
$6.88 | -$1,815,473.04 | 660.1K |
Jun 7 - Jun 9
| |||
Form 4
| -2.32% | -15.67K |
$6.72 | -$152,618.18 | 660.1K |
May 23
| |||
Form 4
|
—
|
0
|
$6.54 | -$1,284,335.12 | 675.77K |
May 9
| |||
Form 4
|
—
|
0
|
$6.21 | -$706,255.58 | 675.77K |
May 4 - May 8
| |||
Form 4
|
—
|
0
|
$6.13 | -$1,314,521.26 | 675.77K |
May 1 - May 3
| |||
Form 4
|
—
|
0
|
$6.20 | -$1,043,555.36 | 675.77K |
Apr 26 - Apr 28
| |||
Form 4
| -2.09% | -14.46K |
$8.80 | -$127,221.60 | 675.77K |
Apr 20
| |||
Form 4
| -2.01% | -14.19K |
$7.30 | -$103,616.20 | 690.23K |
Mar 23
| |||
Form 4
| -1.67% | -11.95K |
$8.43 | -$100,763.79 | 704.42K |
Scheduled
|
Feb 22
| ||
Form 4
| -1.79% | -13.06K |
$8.56 | -$111,767.92 | 716.37K |
Scheduled
|
Jan 24
| ||
Form 4
| -3.19% | -24.04K |
$8.02 | -$192,776.74 | 729.43K |
Scheduled
|
Jan 5
| ||
Form 4
| -13.66% | -119.25K |
$7.46 | -$889,030.88 | 753.47K |
Scheduled
|
Dec 30 - Jan 3
| ||
Form 4
| -1.75% | -16.03K |
$7.10 | -$113,820.10 | 901.65K |
Scheduled
|
Dec 23
| ||
Form 4
| -14.04% | -145.10K |
$7.03 | -$1,019,736.28 | 888.74K |
Scheduled
|
Dec 8 - Dec 9
| ||
Form 4
| -1.52% | -16.00K |
$5.00 | -$80,015.00 | 1.03M |
Nov 20
| |||
Form 4
| -1.49% | -15.92K |
$4.40 | -$70,056.80 | 1.05M |
Scheduled
|
Oct 25
| ||
Form 4
| -1.61% | -17.39K |
$3.07 | -$53,393.44 | 1.07M |
Scheduled
|
Sep 23
| ||
Form 4
| -1.50% | -16.53K |
$3.71 | -$61,326.30 | 1.08M |
Scheduled
|
Aug 24
| ||
Form 4
| -1.51% | -16.90K |
$4.33 | -$73,159.68 | 1.1M |
Scheduled
|
Jul 25
| ||
Form 4
| -1.45% | -16.40K |
$4.34 | -$71,184.68 | 1.12M |
Scheduled
|
Jun 23
| ||
Form 4
| -10.75% | -136.42K |
$3.70 | -$504,757.70 | 1.13M |
May 20
| |||
Form 4
| -0.40% | -5.11K |
$3.84 | -$19,610.88 | 1.27M |
Scheduled
|
Apr 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 4
| -2.63% | -34.43K |
$4.80 | -$165,122.32 | 1.27M |
Scheduled
|
Mar 30
| ||
Form 4
| -5.76% | -80.05K |
$5.06 | -$405,027.70 | 1.31M |
Scheduled
|
Mar 25
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $2.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Immunovant, Inc. (IMVT) Snapshot price: $35.37
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axovant Gene Therapies Ltd. (SIOX) Snapshot price: $0.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||